Sfoglia per Autore
Genomic analysis of circulating tumor DNA to predict endocrine resistance and clonal evolution in patients with prostate cancer : clinical perspectives and research opportunities
2016 D. Trapani, G. Curigliano
Strategies to modulate the immune system in breast cancer : checkpoint inhibitors and beyond
2016 C. Migali, M. Milano, D. Trapani, C. Criscitiello, A. Esposito, M. Locatelli, I. Minchella, G. Curigliano
Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer
2016 C. Criscitiello, A. Esposito, D. Trapani, G. Curigliano
Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy
2017 G. Viale, D. Trapani, G. Curigliano
Entinostat for the treatment of breast cancer
2017 D. Trapani, A. Esposito, C. Criscitiello, L. Mazzarella, M. Locatelli, I. Minchella, S. Minucci, G. Curigliano
The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations
2017 A. Esposito, C. Criscitiello, D. Trapani, G. Curigliano
Targeting the microenvironment in solid tumors
2018 C. Belli, D. Trapani, G. Viale, P. D'Amico, B. Achutti Duso, P. Della Vigna, F. Orsi, G. Curigliano
Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer
2018 B. Duso, D. Trapani, G. Viale, C. Criscitiello, P. D'Amico, C. Belli, L. Mazzarella, M. Locatelli, I. Minchella, G. Curigliano
Liver toxicity in the era of immune checkpoint inhibitors: A practical approach
2018 C. Belli, M. Zuin, L. Mazzarella, D. Trapani, P. D'Amico, E. Guerini-Rocco, B. Achutti Duso, G. Curigliano
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life
2019 S. Morganti, P. Tarantino, E. Ferraro, P. D'Amico, G. Viale, D. Trapani, B.A. Duso, G. Curigliano
The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review
2019 L. Mazzarella, B.A. Duso, D. Trapani, C. Belli, P. D'Amico, E. Ferraro, G. Viale, G. Curigliano
Evaluating triptorelin as a treatment option for breast cancer
2019 E. Ferraro, D. Trapani, E. Marrucci, G. Curigliano
Repurposing anticancer drugs for the management of COVID-19
2020 K. El Bairi, D. Trapani, A. Petrillo, C. Le Page, H. Zbakh, B. Daniele, R. Belbaraka, G. Curigliano, S. Afqir
Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related disease pandemic
2020 P. Tarantino, D. Trapani, G. Curigliano
Pharmacological management of male breast cancer
2020 B.A. Duso, D. Trapani, A. Marra, P. D'Amico, E. Guerini Rocco, N. Fusco, L. Mazzarella, C. Criscitiello, A. Esposito, G. Curigliano
How to treat lobular cancer in the adjuvant setting?
2020 D. Trapani, G. Curigliano
Adjuvant treatment of early male breast cancer
2020 C. Corti, E. Crimini, C. Criscitiello, D. Trapani, G. Curigliano
European Society for Medical Oncology (ESMO) 2018 Congress Twitter analysis : From ethics to results through the understanding of communication and interaction flows
2020 A. Passaro, G. Mackenzie, M. Lambertini, G. Morgan, S. Zimmermann, P. Garrido, G. Curigliano, D. Trapani
The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region
2020 D. Trapani, A. Marra, G. Curigliano
Expression of tumor-associated antigens in breast cancer subtypes
2020 G. Curigliano, V. Bagnardi, M. Ghioni, J. Louahed, V. Brichard, F.F. Lehmann, A. Marra, D. Trapani, C. Criscitiello, G. Viale
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile